老年人的皮肤药物不良反应:一个被低估和可以避免的问题
M Lagassy1, A Lefebvre2, P Carvalho3
1Department of Allergology, Rouen University Hospital, Rouen, France.
Annales de dermatologie et de venereologie
|November 9, 2025
概括
药物不良反应 (ADRs) 在老年人中很常见,特别是与皮肤有关的副作用. 提高对药物过敏的认识可以减少因这些反应而住院的病例.
科学领域:
- 皮肤病学 皮肤病学
- 老年病的医生 老年病的医生
- 药理学 药理学是指药理学的学科.
背景情况:
- 老龄化人口面临的脆弱性和多种药物治疗的风险增加.
- 这增加了药物不良反应 (ADR) 的可能性,包括皮肤学表现.
研究的目的:
- 在皮肤病房的老年患者中表征皮肤ADRs.
- 确定引起这些反应的药物,并评估它们的可避免性.
主要方法:
- 一项针对70岁以上因皮肤ADRs而入院的患者的回顾性研究.
- 包括的反应包括:黄斑囊表 (MPE),AGEP,DRESS,史蒂文斯-约翰逊综合征等.
- 收集的数据:人口统计,药物过敏史,ADR细节,致病药物,可避免性和结果.
主要成果:
- 包括80名患者 (平均年龄82岁);64%是多种药物治疗.
- 65%的皮肤ADRs不是严重的 (60%的MPE),35%是严重的 (23%的DRESS,9%的AGEP).
- 抗生素是最常见的原因 (85%);21%的副作用是可以避免的. 15%的人在重新挑战时经历了新的不良反应.
结论:
- 皮肤ADR是老年患者的一个重要问题,通常与多种药物治疗有关.
- 提高对药物过敏史的临床意识至关重要.
- 这可以提高老年人护理,减少皮肤病房的入院.
更多相关视频
相关概念视频
Drug Dosing: Geriatric Patients
215
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
213
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
213
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
188
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
188
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
221
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
221
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
226
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
226


